MedPath

The therapeutic effects of AST-120 and/or magnesium on coronary artery calcification in chronic kidney disease: A Randomized Controlled Trial

Not Applicable
Conditions
on-dialysis chronic kidney disease
Registration Number
JPRN-UMIN000009738
Lead Sponsor
Osaka University Graduate School of Medicine, Geriatric Medicine and Nephrology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients already treated with AST-120 or magnesium at enrollment 2) Patients with prior allergies to AST-120 or magnesium 3) Patients with coronary stent 4) Patients expected to initiate dialysis within 1 year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath